Extension of Dynamic Network Biomarker using the propensity score method: Simulation of causal effects on variance and correlation coefficient

Satoru Shinoda · 2025

Read Extension of Dynamic Network Biomarker using the propensity score method: Simulation of causal effects on variance and correlation coefficient by Satoru Shinoda (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2505-13846.txt.

Introduction

Doctors sometimes watch for a warning pattern called a dynamic network biomarker, built from how strongly biological signals vary and move together, to catch a disease state changing. Satoru Shinoda and co-authors note a weak point: real patient groups differ in background traits, and those differences can bias the biomarker. Causal adjustment methods exist for averages, but hardly any work covers variance and correlation, the biomarker's ingredients.

The team tests one adjustment, propensity score matching, in Monte Carlo simulations. Matching patients with similar background profiles before comparing groups reduced the bias and improved the comparisons in their runs. The authors conclude that this standard causal tool can be carried over to biomarkers built on variance and correlation, and they recommend it when such markers are applied to clinical data.

Catalog record

CREATORSatoru Shinoda
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE15 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2505-13846

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Extension of Dynamic Network Biomarker using the propensity score method: Simulation of causal effects on variance and correlation coefficient Satoru Shinoda Abstract In clinical biomarker studies, the Dynamic Network Biomarker (DNB) is sometimes used. DNB is a composite variable derived from the variance and the Pearson correlation coefficient of biological signals. When applying DNB to clinical data, it is important to account for confounding bias. However, little attention has been paid to statistical causal inference methods for variance and correlation coefficients. This study evaluates confounding adjustment using propensity score matching (PSM) through Monte Carlo simulations. Our results support the use of PSM to reduce bias and improve group comparisons when DNB is applied to clinical data. Keywords : Causal effect on the correlation coefficient, causal effect on the variance, propensity score matching, simulation study. 1. Introduction Recent research has focused on quantitatively characterizing the intermediate state between health and disease, commonly referred to as the “pre-disease” state (Chen et~al. , 2012; Aihara et~al. ., 2022). The concept of pre-disease dates back to the ancient Chinese medical text “Huangdi Neijing” and remains relevant in modern health policy, where health and disease are increasingly viewed as a continuum. Since pre-disease can revert to a healthy state with timely intervention but may progress to disease if left undetected, early detection is critical. However, due to the lack of a clear definition, rigorous and quantitative investigation of this state remains essential (Aihara et~al. ., 2022). Traditional biomarker studies for early disease detection have relied on static features of biological signals, such as mean or instantaneous values. However, these approaches have limitations in detecting early signs of deterioration. The Dynamic Network Biomarker (DNB) was introduced as a method that focuses on signal variability, such as fluctuations (Chen et~al. ., 2012). DNB has shown useful in identifying early signs of critical transitions in mouse models (Koizumi et~al. ., 2019), and more recently, its potential has been demonstrated in human data as well (Fang et~al. ., 2023; Zhang et~al. ., 2024; Gao et~al. ., 2024; Zhang et~al. ., 2023). DNB is a simple statistic defined as the product of the standard deviation and the Pearson correlation coefficient of biological signals. However, applying DNB to clinical data introduces challenges not present in mouse models, such as individual variability and confounders. In particular, adjustment for confounders is essential when comparing DNB values between groups, but previous studies have not sufficiently examined this point. When using clinical data, type I errors (mistakenly detecting differences when none exist) must be minimized, particularly because DNB is often used in exploratory analyses where numerous biomarker candidates are screened. The population causal effect on variance, explained as the difference in variances between exposed and unexposed groups, has been introduced in the literature (Hernán and Robins, 2020). While causal inference for means has been widely studied, little work has focused on causal inference for variance or correlation coefficients. For example, a Web of Science search using the terms “causal effect on the variance,” “variance causal inference,” or “causal variance” yielded only 11 results, and none on arXiv. Although studies such as Kuroki and Miyakawa (2003) and Tezuka and Kuroki (2023) have proposed point estimation approaches based on Pearl’s structural equation models, these are not directly suited for statistical testing in group comparisons. We found no studies applying Rubin’s framework of propensity scores (PS) to causal inference for variance or Pearson correlation coefficient. This study focuses on the causal effects of variance and Pearson correlation coefficient as fundamental components of DNB. We consider whether propensity score matching (PSM) can effectively adjust for confounding when comparing between groups. Using Monte Carlo simulations, we evaluate the extent to which confounding may lead to false conclusions in situations where no true group differences exist. 2. Materials and methods 2.1. Brief overview of PS method The PS is defined as the conditional probability of receiving a particular exposure, given a set of observed confounders, and is expressed as \Pr[X=1\mid Z] , where X and Z are exposure and confounder variables. PS is also known as a balancing score, as it has the property that, within groups sharing the same PS, the assignment of exposure is independent of the confounders. This property enables the estimation of exposure effects free from confounding bias by matching individuals with similar PS values. Therefore, the estimates obtained through PSM can be interpreted as causal effects. More detailed discussions of PS methods can be found elsewhere (Rosenbaum and Rubin, 1983; D’Agostino, 1998; Joffe and Rosenbaum, 1999). In this study, PSM was performed using the MatchIt package in R (R Core Team, 2025; Ho et~al. ., 2011). The matchit() function offers a flexible tool for PS-based matching, allowing treatment and control groups to be balanced by specifying a model formula. As a widely used and easily interpretable approach, nearest neighbor matching was employed, with a 1:1 matching ratio and a caliper of 0.2. 2.2. Monte Carlo simulation study This study considers the extent to which PSM can reduce the type I errors under the presence of confounding, compared to unadjusted. Simulation data were generated based on the causal structure (DAG) shown in Figure 1. Fig. 1: Directed acyclic graph for simulation study. We considered three confounders, Z_{1} , Z_{2} , and Z_{3} , each independently sampled from the standard normal distribution \mathcal{N}(0,1) . The exposure variable X given Z_{1} , Z_{2} , and Z_{3} follows a Bernoulli distribution with a conditional mean given by the function: \Pr(X=1\mid Z_{1},Z_{2},Z_{3})=\Phi(\alpha_{1}Z_{1}+\alpha_{2}Z_{2}+\alpha_{3}Z_{3}) , where \Phi(\cdot) denotes the cumulative distribution function of the standard normal distribution. The response variables Y_{i} (for i=1,2 ) were modeled without a direct effect from X , and instead were functions of the confounders Z_{1} , Z_{2} , and Z_{3} , and an error term: Y_{i}=\beta_{1}Z_{1}+\beta_{2}Z_{2}+\beta_{3}Z_{3}+\varepsilon. The error term \varepsilon follows a normal distribution with mean zero and variance \sigma^{2} , where \sigma depends on Z_{1} , Z_{2} , and Z_{3} , thereby introducing heteroscedasticity: \sigma=\exp\left(\gamma_{1}Z_{1}+\gamma_{2}Z_{2}+\gamma_{3}Z_{3}\right). Thus, the model represents a weighted regression framework that does not assume homoscedasticity. The two outcomes Y_{1} and Y_{2} were used to calculate the correlation coefficient within each group. While a strong correlation between them is expected, the absolute strength of this correlation is not essential to evaluating group differences. To examine the impact of confounding adjustment, we compared the following four estimation approaches: 1. Unadjusted : No consideration of confounders in group comparisons (baseline scenario) 2. PSM1 : Matching based on a propensity score estimated using only Z_{1} 3. PSM2 : Propensity score estimated using Z_{1} and Z_{3} 4. PSM3 : Propensity score estimated using all three confounders (ideal adjustment scenario) For variance comparison, we used the var.test() function in R. To test differences in Pearson correlation coefficients, we used the cocor.indep.groups() function from the cocor package, which implements Fisher’s z -transformation method (Fisher, 1925; Diedenhofen and Musch, 2015), a standard approach in DNB studies. 2.3. Evaluation of PS model performance To evaluate the performance of group comparisons under different levels of confounding adjustment, we analyzed the simulation results using three indicators: (1) Type I error rate ( \alpha -error), (2) Bias, and (3) Mean squared deviation (MSD). We also calculated the average post-matching sample size (ASS). \alpha -error was

Read the complete text